We conclude that components of the IGF-1 signaling and inflammatory cytokine pathways (and potentially the cross-talk between these pathways) should be considered in future studies of targets and strategies for preventing obesity-related colon cancer. The gene discussed is IGF1; the disease is malignant colon neoplasm.